Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bamboo US Bidco is a special purpose acquisition vehicle formed by the private equity firm GHO Capital Partners to facilitate the acquisition of Genesis Research, a leading provider of Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) services. The company operates as a holding entity for Genesis Research, which provides data-driven strategy and evidence-generation services to the life sciences industry. Through this structure, the organization supports pharmaceutical and biotech clients in optimizing drug development and demonstrating product value to payers and regulators. Its primary focus is on leveraging advanced data analytics and epidemiological expertise to improve healthcare decision-making.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bamboo US Bidco.